MyFinsight
Home
Blog
About
Mersana Therapeutics, Inc. (MRSN)
Mersana Therapeutics, Inc. (MRSN)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$20,581K
Free Cash flow
-$3,192K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Deferred revenue
Stock-based compensation
Non-cash operating lease expense
Others
Negative Cash Flow Breakdown
Repayment of debt
Net loss
Operating lease liabilities
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-09-30
2025-06-30
Net loss
-7,545
-48,419
Depreciation
83
603
Impairment loss on property and equipment
-25
-563
Net amortization of premiums and discounts on marketable securities
0
140
Stock-based compensation
1,154
4,764
Non-cash operating lease expense
859
1,683
Loss on extinguishment of debt
-378
-
Other non-cash items
3
-154
Accounts receivable
-98
266
Prepaid expenses and other current assets
525
142
Other assets
0
0
Accounts payable
-530
-1,407
Accrued expenses
-370
-3,781
Operating lease liabilities
-976
-1,878
Other liabilities
0
-594
Deferred revenue
4,160
-3,068
Net cash used in operating activities
-3,192
-51,928
Maturities of marketable securities
0
27,000
Purchase of marketable securities
0
0
Proceeds from sale of property and equipment
372
395
Purchase of property and equipment
0
0
Net cash provided by (used in) investing activities
372
27,395
Net proceeds from at-the-market facilities
0
0
Proceeds from exercise of stock options
0
0
Proceeds from sales of common stock under espp
0
29
Repayment of debt
17,729
6,250
Payments under finance lease obligations
32
24
Net cash (used in) provided by financing activities
-17,761
-6,245
Decrease in cash, cash equivalents and restricted cash
-20,581
-30,778
Cash and cash equivalents at beginning of period
108,228
-
Cash and cash equivalents at end of period
56,869
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from sale of
property and equipment
$372K
Net cash provided by
(used in) investing...
$372K
Decrease in cash, cash
equivalents and restricted...
-$20,581K
Canceled cashflow
$372K
Deferred revenue
$4,160K
Stock-based compensation
$1,154K
Non-cash operating lease
expense
$859K
Loss on
extinguishment of debt
-$378K
Accounts receivable
-$98K
Depreciation
$83K
Impairment loss on property
and equipment
-$25K
Net cash (used in)
provided by financing...
-$17,761K
Net cash used in
operating activities
-$3,192K
Canceled cashflow
$6,757K
Repayment of debt
$17,729K
Payments under finance
lease obligations
$32K
Net loss
-$7,545K
Operating lease
liabilities
-$976K
Accounts payable
-$530K
Prepaid expenses and
other current assets
$525K
Accrued expenses
-$370K
Other non-cash items
$3K
Buy us a coffee